Published in Lancet on December 16, 1978
Gall stones and gall bladder motility. Gut (1993) 1.21
Gut hormone release after intestinal resection. Gut (1982) 1.18
Gut hormones in tropical malabsorption. Br Med J (1979) 1.05
Quantitative analysis of pancreatic polypeptide cell distribution in the human pancreas. PLoS One (2013) 1.01
Human pancreatic icosapeptide: isolation, sequence, and immunocytochemical localization of the COOH-terminal fragment of the pancreatic polypeptide precursor. Proc Natl Acad Sci U S A (1984) 0.96
Release of cholecystokinin and gallbladder contraction before and after gastrectomy. Ann Surg (1987) 0.92
The role of neurotensin in human gallbladder motility. Ann Surg (1985) 0.86
Effects of pancreatic polypeptide on insulin action in exocrine secretion of isolated rat pancreas. J Physiol (1993) 0.83
Pancreatic polypeptide. J Clin Pathol Suppl (Assoc Clin Pathol) (1978) 0.83
Pathologic pancreatic endocrine cell hyperplasia. World J Gastroenterol (2011) 0.83
Sporadic pancreatic polypeptide secreting tumors (PPomas) of the pancreas. World J Surg (2008) 0.83
Gut-hormone profile in totally pancreatectomised patients. Gut (1981) 0.81
Pancreatic polypeptide and calcitonin secretion from a pancreatic tumour-clinical improvement after hepatic artery embolization. Postgrad Med J (1983) 0.81
Recent advances in pancreatic hormone research. Postgrad Med J (1983) 0.80
The gastrointestinal endocrine system. Can Med Assoc J (1980) 0.77
Identification, characterization and feeding response of peptide YYb (PYYb) gene in grass carp (Ctenopharyngodon idellus). Fish Physiol Biochem (2013) 0.76
Effect of increasing oral doses of loperamide on gallbladder motility in man. Br J Clin Pharmacol (1990) 0.75
Gastrointestinal hormones in alcoholic patients with and without liver disease. Ulster Med J (1986) 0.75
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimers Dement (Amst) (2017) 0.75
The effect of oral alcohol on gastroenteropancreatic hormones in volunteers. Ulster Med J (1985) 0.75
Serum immunoreactive trypsin concentrations in diabetic children. J Clin Pathol (1980) 0.75
Stimulation of exocrine pancreatic secretion by met-enkephalin. Gut (1986) 0.75
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 6.03
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut (1995) 4.70
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med (1995) 4.56
One week eradication regimen for Helicobacter pylori. Lancet (1991) 4.50
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut (2010) 4.50
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology (2000) 3.80
THE ANEMIA OF INFECTION. III. THE UPTAKE OF RADIO-ACTIVE IRON IN IRON-DEFICIENT AND IN PYRIDOXINE-DEFICIENT PIGS BEFORE AND AFTER ACUTE INFLAMMATION. J Clin Invest (1947) 3.73
Ghrelin causes hyperphagia and obesity in rats. Diabetes (2001) 3.62
A glucagonoma syndrome. Lancet (1974) 3.56
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ (1996) 3.33
Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut (1991) 3.27
Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet (1973) 3.22
Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet (1976) 3.08
MIST VR: a virtual reality trainer for laparoscopic surgery assesses performance. Ann R Coll Surg Engl (1997) 3.04
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology (2005) 2.80
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78
Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut (1971) 2.75
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Neuron-specific enolase is produced by neuroendocrine tumours. Lancet (1981) 2.63
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Measurement of fasting and postprandial plasma VIP in man. Gut (1978) 2.48
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1982) 2.48
Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology (1983) 2.37
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol (2004) 2.27
Gut-hormone profile in coeliac disease. Lancet (1978) 2.25
Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet (1989) 2.25
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab (2001) 2.24
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 2.20
Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol (2001) 2.20
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther (2014) 2.18
Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun (1979) 2.16
Gut hormones and appetite control. Gastroenterology (2007) 2.16
A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology (1998) 2.14
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut (1991) 2.04
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03
The role of the sympathetic innervation in the control of plasma glucagon concentration in the calf. J Physiol (1973) 2.01
ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ (2001) 1.99
Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease. Br Med J (Clin Res Ed) (1982) 1.96
111Indium autologous leucocytes in inflammatory bowel disease. Gut (1983) 1.95
How to beautify your old hospital. Br Med J (Clin Res Ed) (1984) 1.95
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Campylobacter pylori in esophagus, antrum, and duodenum. A histological and microbiological study. Dig Dis Sci (1989) 1.92
Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology (1977) 1.92
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg (2006) 1.91
Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med (1973) 1.90
Anticoagulation control with warfarin by junior hospital doctors. J R Soc Med (1987) 1.90
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes (1999) 1.90
Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest (1997) 1.89
Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci (1984) 1.88
Evidence for a complex regulating the in vivo activities of early enzymes induced by bacteriophage T4. J Biol Chem (1974) 1.87
Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet (1990) 1.85
Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J Physiol (1982) 1.84
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80
A procedure-specific systematic review and consensus recommendations for postoperative analgesia following laparoscopic cholecystectomy. Surg Endosc (2005) 1.75
Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut (1994) 1.75
Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab (2000) 1.75
Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75
Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology (1997) 1.74
Rapid diagnosis of Campylobacter pyloridis infection. J Clin Pathol (1987) 1.74
The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Br J Surg (1974) 1.73
Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73
Histological identification of Campylobacter using Gimenez technique in gastric antral mucosa. J Clin Pathol (1987) 1.72
Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab (1996) 1.72
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab (2003) 1.71
Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology (1980) 1.70
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
An enteroglucagon tumour. Gut (1972) 1.69
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Characteristics of the deo operon: role in thymine utilization and sensitivity to deoxyribonucleosides. J Bacteriol (1968) 1.68
Motilin and the interdigestive migrating motor complex in man. Dig Dis Sci (1979) 1.67
Albumin, fibrinogen and transferrin synthesis in isolated rat hepatocyte suspensions. A model for the study of plasma protein synthesis. Biochem J (1975) 1.66
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
A radioimmunoassay for neurotensin in human plasma. J Endocrinol (1979) 1.66